134 related articles for article (PubMed ID: 17907597)
1. Peroxiredoxins and antioxidant enzymes in pilocytic astrocytomas.
Nordfors K; Haapasalo J; Helén P; Paetau A; Paljärvi L; Kalimo H; Kinnula VL; Soini Y; Haapasalo H
Clin Neuropathol; 2007; 26(5):210-8. PubMed ID: 17907597
[TBL] [Abstract][Full Text] [Related]
2. Expression of antioxidant enzymes in astrocytic brain tumors.
Haapasalo H; Kyläniemi M; Paunul N; Kinnula VL; Soini Y
Brain Pathol; 2003 Apr; 13(2):155-64. PubMed ID: 12744469
[TBL] [Abstract][Full Text] [Related]
3. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant enzymes in renal cell carcinoma.
Soini Y; Kallio JP; Hirvikoski P; Helin H; Kellokumpu-Lehtinen P; Tammela TL; Peltoniemi M; Martikainen PM; Kinnula LV
Histol Histopathol; 2006 Feb; 21(2):157-65. PubMed ID: 16329040
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung.
Kinnula VL; Pääkkö P; Soini Y
FEBS Lett; 2004 Jul; 569(1-3):1-6. PubMed ID: 15225599
[TBL] [Abstract][Full Text] [Related]
6. Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors.
Järvelä S; Rantala I; Rodriguez A; Kallio H; Parkkila S; Kinnula VL; Soini Y; Haapasalo H
BMC Cancer; 2010 Mar; 10():104. PubMed ID: 20307276
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma.
Kinnula VL; Lehtonen S; Sormunen R; Kaarteenaho-Wiik R; Kang SW; Rhee SG; Soini Y
J Pathol; 2002 Mar; 196(3):316-23. PubMed ID: 11857495
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival.
Järvelä S; Bragge H; Paunu N; Järvelä T; Paljärvi L; Kalimo H; Helén P; Kinnula V; Soini Y; Haapasalo H
J Neurooncol; 2006 Apr; 77(2):131-40. PubMed ID: 16292483
[TBL] [Abstract][Full Text] [Related]
9. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
10. Cellular proliferation in pilocytic and diffuse astrocytomas.
Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
[TBL] [Abstract][Full Text] [Related]
11. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
[TBL] [Abstract][Full Text] [Related]
12. Peroxiredoxins and their expression in ependymomas.
Haapasalo T; Nordfors K; Järvelä S; Kok E; Sallinen P; Kinnula VL; Haapasalo HK; Soini Y
J Clin Pathol; 2013 Jan; 66(1):12-7. PubMed ID: 23076395
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas.
Bur H; Haapasaari KM; Turpeenniemi-Hujanen T; Kuittinen O; Auvinen P; Marin K; Koivunen P; Sormunen R; Soini Y; Karihtala P
Histopathology; 2014 Sep; 65(3):319-27. PubMed ID: 24698430
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas.
Valkonen M; Haapasalo H; Rilla K; Tyynelä-Korhonen K; Soini Y; Pasonen-Seppänen S
BMC Cancer; 2018 Jun; 18(1):664. PubMed ID: 29914429
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxins in breast carcinoma.
Karihtala P; Mäntyniemi A; Kang SW; Kinnula VL; Soini Y
Clin Cancer Res; 2003 Aug; 9(9):3418-24. PubMed ID: 12960131
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of urokinase-type plasminogen activator in human gliomas.
Hsu DW; Efird JT; Hedley-Whyte ET
Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin system in premature and newborn biology.
Das KC
Antioxid Redox Signal; 2004 Feb; 6(1):177-84. PubMed ID: 14713349
[TBL] [Abstract][Full Text] [Related]
18. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
19. Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma.
Peroja P; Haapasaari KM; Mannisto S; Miinalainen I; Koivunen P; Leppä S; Karjalainen-Lindsberg ML; Kuusisto ME; Turpeenniemi-Hujanen T; Kuittinen O; Karihtala P
Virchows Arch; 2016 May; 468(5):623-30. PubMed ID: 26983700
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin networks in the malarial parasite Plasmodium falciparum.
Nickel C; Rahlfs S; Deponte M; Koncarevic S; Becker K
Antioxid Redox Signal; 2006; 8(7-8):1227-39. PubMed ID: 16910770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
